Chemokines in lung injury: Thomas A. Neff lecture

Chest

Volumn 116, Issue SUPPL., 1999, Pages 103S-110S

  Strieter, Robert M ^a   Kunkel, Steven L ^a   Keane, Michael P ^a   Standiford, Theodore J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOTACTIC FACTOR; CHEMOTAXIN; CYTOKINE; INTERLEUKIN 1; LYMPHOTACTIN; TUMOR NECROSIS FACTOR;

CONFERENCE PAPER; CYTOKINE RELEASE; INFLAMMATION; LUNG INJURY; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032814287     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.suppl_1.103S     Document Type: Conference Paper

References (80)

1. Larrick JW, Kunkel SL. The role of tumor necrosis factor and interleukin-1 in the immunoinflammatory response. Pharmacol Res 1988; 5:129-139
2. Kunkel SL, Remick DG, Strieter RM, et al. Mechanisms that regulate the production and effects of tumor necrosis factor α. Crit Rev Immunol 1989; 9:93-117
3. Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987; 56:234-248
4. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of the inflammatory responses. J Cell Biol 1988; 107:1269-1277
5. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-2147
6. Dinarello CA. Biology of interleukin 1. FASEB J 1988; 2:108-115
7. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163:1433-1450
8. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989; 44:153-205
9. Cerami A. Inflammatory cytokines. Clin Immunol Immunopathol 1992; 62:S3-S10
10. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346:425-434
11. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-1035
12. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, et al. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243:1160-1165
13. Strieter RM, Kunkel SL, Showell HJ, et al. Monokine-induced gene expression of human endothelial cell-derived neutrophil chemotactic factor. Biochem Biophys Res Commun 1988; 156:1340-1345
14. Strieter RM, Kunkel SL, Showell HJ, et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1-beta. Science 1989; 243:1467-1469
15. Bevilacqua MP, Pober JS, Majeau GR, et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83:4533-4537
16. Stern DM, Kaiser E, Nawroth PP. Regulation of the coagulation system by vascular endothelial cells. Haemostasis 1988; 18:202-214
17. Crutchley DJ, Conanan LB. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells. J Biol Chem 1986; 261:154-159
18. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235:1348-1352
19. Clouse LH, Comp PC. The regulation of hemostasis: the protein C system. N Engl J Med 1986; 314:1298-1304
20. Moore KL, Andreoli SP, Esmon NL, et al. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79:124-130
21. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77:1627-1635
22. Ulich TR, Watson LR, Yin SM, et al. The intratracheal administration of endotoxin and cytokines: I. Characterization of LPS-induced inflammatory infiltrate. Am J Pathol 1991; 138:1485-1496
23. Eisenberg SP, Brewer MT, Verdeber E, et al. IL-1 receptor antagonist (IL-1ra) is a member of the IL-1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci USA 1991; 88:5232-5236
24. Eisenberg SP, Evans RJ, Arend WP, et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990; 343: 343-346
25. Mazzei GJ, Seckinger PL, Dayer JM, et al. Purification and characterization of a 26-kDa competitive inhibitor of interleukin-1. Eur J Immunol 1990; 20:683-689
26. Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Science 1990; 343:336-340
27. Carter DB, Deibel MR, Dunn CJ, et al. Purification, cloning, expression, and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990; 344:633-638
28. Arend WP. Interleukin-1 receptor antagonist - a new member of the interleukin-1 family. J Clin Invest 1991; 88:1445-1451
29. Ohlsson K, Bjork P, Bergenfeldt M, et al. IL-1ra reduces mortality from endotoxin shock. Nature 1990; 348:550-552
30. Ulich TR, Yin SM, Guo KZ, et al. The intratracheal administration of endotoxin and cytokines: III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation. Am J Pathol 1991; 138: 521-524
31. Tracey KJ, Fong Y, Hesse DG. Anti-cachectin/INF monoclonal antibodies prevent septic shock during lethal bacteremia in baboons. Nature 1987; 330:662-666
32. Tracy KJ, Lowry SF. The role of cytokine mediators in septic shock. Adv Surg 1990; 23:21-56
33. Sipe JD. The molecular biology of interleukin 1 and the acute phase response. Adv Intern Med 1989; 34:1-20
34. Shalaby MR, Halgunset J, Haugen OA, et al. Cytokine-associated tissue injury and lethality in mice: a comparative study. Clin Immunol Immunopathol 1991; 61:69-82
35. 100 septic shock following therapy with antibody to tumor necrosis factor (INF-alpha). Circ Shock 1990; 30:279-292
36. Remick DG, Strieter RM, Eskandari MK, et al. Role of tumor necrosis factor-α in lipopolysaccharide-induced pathologic alterations. Am J Pathol 1990; 136:49-60
37. Remick DG, Strieter RM, Lynch JP III, et al. In vivo dynamics of murine tumor necrosis factor-α gene expression: kinetics of dexamethasone-induced suppression. Lab Invest 1989; 60:766-771
38. Michie HR, Mangue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318:1481-1484
39. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with menigococcal disease. Lancet 1987; 2:355-357
40. Girardin E, Grau GE, Dayer JM, et al. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988; 319:397-400
41. Marks JD, Marks CB, Luce JM, et al. Plasma tumor necrosis in patients with septic shock: mortality rate, incidence of adult respiratory distress syndrome. Am Rev Respir Dis 1990; 141:94-97
42. Strieter RM, Kunkel SL. Chemokines and the lung. In: Crystal R, West J, Weibel E, et al, eds. Lung: scientific foundations. 2nd ed. Raven Press, New York, NY: 1997; 155-186
43. Rollins BJ. Chemokines. Blood 1997; 90:909-928
44. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-445
45. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84:1045-1049
46. Oppenheim JJ, Zachariae OC, Mukaida N, et al. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu Rev Immunol 1991; 9:617-648
47. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992; 12:17-46
48. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994; 55:97-179
49. Taub D. C-C chemokines: an overview. In: Koch A, Strieter R, eds. Chemokines in disease. Austin, TX: RG Landes, Co, 1996; 27-54
50. Taub DD, Oppenheim JJ. Chemokines, inflammation and immune system. Ther Immunol 1994; 1:229-246
51. Farber JM. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997; 61:246-257
52. Walz A, Kunkel SL, Strieter RM. CXC chemokines - an overview. In: Strieter RM, ed. Chemokines in disease. Austin, TX: RG Landes Co, 1996; 1-26
53. Walz A, Strieter RM, Schnyder S. Neutrophil-activating peptide ENA-78. Adv Exp Med Biol 1993; 351:129-137
54. Walz A, Burgener R, Car B, et al. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. J Exp Med 1991; 174: 1355-1362
55. Proost P, Wolf-Peeters CD, Conings R, et al. Identification of a novel granulocyte chemotactic protein (GCP-1) from human tumor cells: in vitro and in vivo comparison with natural forms of GROα, IP-10, and IL-8. J Immunol 1993; 150:1000-1010
56. Strieter RM, Kunkel SL, Shanafelt AB, et al. CXC chemokines in regulation of angiogenesis. In: Koch AE, Strieter RM, eds. Chemokines in disease. Austin, TX: RG Landes, 1996; 195-210
57. Strieter RM, Polverini PJ, Kunkel SL, et al. The functional role of the ELR motif in CXC chemokine-mediated angio-genesis. J Biol Chem 1995; 270:27348-27357
58. Rani MRS, Foster GR, Leung S, et al. Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem 1996; 271:22878-22884
59. Jorens PG, VanDame J, DeBecker W, et al. Interleukin-8 in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine 1992; 4:592-597
60. Miller EJ, Cohen AB, Nago S, et al. Elevated levels of NAP-1/Interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146:427-432
61. Hack CE, Hart M, Strack-vanSchijindel RJM, et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992; 60:2835-2842
62. Chollet-Martin S, Montravers P, Gilbert C, et al. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 1993; 61:4553-4559
63. Donnelly TJ, Meade P, Jagels M, et al. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 1994; 22:768-776
64. Donnelly SC, Strieter RM, Kunkel SL, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341:643-647
65. Metinko AP, Kunkel SL, Standiford TJ, et al. Anoxia-hyperoxia induces monocyte derived interleukin-8. J Clin Invest 1992; 90:791-798
66. Karakurum M, Shreeniwas R, Chen J, et al. Hypoxia induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 1994; 93:1564-1570
67. Sekido N, Mukaido N, Harada A, et al. Prevention of lung reperfusion injury by a monoclonal antibody against interleukin-8. Nature 1993; 365:654-657
68. Colletti LM, Kunkel SL, Walz A, et al. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat: the role of epithelial neutrophil activating protein. J Clin Invest 1995; 95:134-141
69. Colletti LM, Kunkel SL, Green M, et al. Hepatic inflammation following 70% hepatectomy may be related to up-regulation of epithelial neutrophil activating protein-78 [see comments]. Shock 1996; 6:397-402
70. Colletti LM, Kunkel SL, Green M, et al. Post-ischemic shunt following hepatic ischemia/reperfusion does not affect tissue chemokine levels of tissue injury. Shock 1996; 5:371-377
71. Colletti LM, Kunkel SL, Walz A, et al. The role of cytokine networks in the local liver injury following hepatic ischemia/ reperfusion in the rat. Hepatology 1996; 23:506-514
72. Frevert CW, Farone A, Danaee H, et al. Functional characterization of rat chemokine macrophage inflammatory protein-2. Inflammation 1995; 19:133-142
73. Frevert CW, Huang S, Danaee H, et al. Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J Immunol 1995; 154:335-344
74. Boylan AM, Hebert CA, Sadick M, et al. Interleukin-8 is a major component of pleural liquid chemotactic activity in a rabbit model of endotoxin pleurisy. Am J Physiol 1994; 267:L137-L144
75. Broaddos VC, Boylan AM, Hoeffel JM, et al. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol 1994; 152:2960-2667
76. Standiford TJ, Kunkel SL, Greenberger MJ, et al. Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol 1996; 59:24-28
77. Greenberger MJ, Strieter RM, Kunkel SL, et al. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis 1996; 173:159-165
78. Standiford TJ, Strieter RM, Greenberger MJ, et al. Expression and regulation of chemokines in acute bacterial pneumonia. Biol Signals 1996; 5:203-208
79. Tsai WC, Strieter RM, Wilkowski JM, et al. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumonia in mice. J Immunol 1998; 161:2435-2440
80. Lira SA, Fuentes ME, Strieter RM, et al. Transgenic methods to study chemokine function in lung and central nervous system. Methods Enzymol 1997; 287:304-318